BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37677983)

  • 1. YY1-regulated lncRNA SOCS2-AS1 suppresses HCC cell stemness and progression via miR-454-3p/CPEB1.
    Zhong F; Wang Y
    Biochem Biophys Res Commun; 2023 Oct; 679():98-109. PubMed ID: 37677983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HnRNPU-AS1 inhibits the proliferation, migration and invasion of HCC cells and induces autophagy through miR-556-3p/ miR-580-3p/SOCS6 axis.
    Zhang L; Zhao Y; Guan H; Zhang D
    Cancer Biomark; 2022; 34(3):443-457. PubMed ID: 35275521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis.
    Zhou Y; Li K; Zou X; Hua Z; Wang H; Bian W; Wang H; Chen F; Dai T
    Bioengineered; 2021 Dec; 12(2):10862-10877. PubMed ID: 34666613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis.
    Bi HQ; Li ZH; Zhang H
    Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):567-574. PubMed ID: 32224127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA NUTM2A-AS1 aggravates the progression of hepatocellular carcinoma by activating the miR-186-5p/KLF7-mediated Wnt/beta-catenin pathway.
    Long J; Liu L; Yang X; Zhou X; Lu X; Qin L
    Hum Cell; 2023 Jan; 36(1):312-328. PubMed ID: 36242728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.
    Li H; Zhang B; Ding M; Lu S; Zhou H; Sun D; Wu G; Gan X
    Hepatol Int; 2019 May; 13(3):277-292. PubMed ID: 31069760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
    Guo X; Wang Y
    Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
    Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
    Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
    Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
    Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA ZFPM2-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the miR-576-3p/HIF-1α axis.
    Song Y; Jin X; Liu Y; Wang S; Bian F; Zhao Q; Shi H; Gao Z
    Anticancer Drugs; 2021 Sep; 32(8):812-821. PubMed ID: 34102651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA matrilineal expression gene 3 inhibits hepatocellular carcinoma progression by targeting microRNA-5195-3p and regulating the expression of forkhead box O1.
    Li M; Liao H; Wu J; Chen B; Pang R; Huang J; Zhu Y
    Bioengineered; 2021 Dec; 12(2):12880-12890. PubMed ID: 34895065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis.
    Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S
    Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KDM4A-AS1 Promotes Cell Proliferation, Migration, and Invasion via the miR-4306/STX6 Axis in Hepatocellular Carcinoma.
    Cao W; Ren Y; Liu Y; Cao G; Chen Z; Wang F
    Crit Rev Eukaryot Gene Expr; 2024; 34(4):55-68. PubMed ID: 38505873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1).
    Yang Y; Shi L; Zhang D; Wu D; An Y; Zhang Y; Chen X
    Bioengineered; 2021 Dec; 12(1):6713-6723. PubMed ID: 34519634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1).
    Mou Y; Sun Q
    Bioengineered; 2022 Jan; 13(1):746-758. PubMed ID: 34859735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of C1QTNF1-AS1 regulation in human hepatocellular carcinoma.
    Han W; Yu G; Meng X; Hong H; Zheng L; Wu X; Zhang D; Yan B; Ma Y; Li X; Wang Q
    Mol Cell Biochem; 2019 Oct; 460(1-2):37-51. PubMed ID: 31222560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p/FGF2 axis.
    Ou H; Qian Y; Ma L
    Aging (Albany NY); 2023 Jul; 15(13):6100-6116. PubMed ID: 37432067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
    Liu Z; Ouyang G; Lu W; Zhang H
    Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.